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ABSTRACT 57 
 58 
Immigrants from high tuberculosis (TB) incidence regions are a risk group for 59 
TB in low-incidence countries such as Switzerland. In a previous analysis of a 60 
nationwide collection of 520 Mycobacterium tuberculosis isolates from 2000-2008, we 61 
identified 35 clusters comprising 90 patients based on standard genotyping (24-loci 62 
MIRU-VNTR and spoligotyping). Here, we used whole genome sequencing (WGS) to 63 
revisit these transmission clusters. Genome-based transmission clusters were 64 
defined as isolate pairs separated by ≤12 single nucleotide polymorphisms (SNPs). 65 
WGS confirmed 17/35 (49%) MIRU-VNTR clusters; the other 18 clusters contained 66 
pairs separated by >12 SNPs. Most transmission clusters (3/4) of Swiss-born 67 
patients were confirmed by WGS, as opposed to 25% (4/16) of clusters involving only 68 
foreign-born patients. The overall clustering proportion using standard genotyping 69 
was 17% (90 patients, 95% confidence interval [CI]: 14-21%), but only 8% (43 70 
patients, 95% CI: 6-11%) using WGS. The clustering proportion was 17% (67/401, 71 
95% CI: 13-21%) using standard genotyping and 7% (26/401, 95% CI: 4-9%) using 72 
WGS among foreign-born patients, and 19% (23/119, 95% CI: 13-28%) and 14% 73 
(17/119, 95% CI: 9-22%), respectively, among Swiss-born patients. Using weighted 74 
logistic regression, we found weak evidence for an association between birth origin 75 
and transmission (aOR 2.2, 95% CI: 0.9-5.5, comparing Swiss-born patients to 76 
others). In conclusion, standard genotyping overestimated recent TB transmission in 77 
Switzerland when compared to WGS, particularly among immigrants from high TB 78 
incidence regions, where genetically closely related strains often predominate. We 79 
recommend the use of WGS to identify transmission clusters in low TB incidence 80 
settings. 81 
  82 
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INTRODUCTION 83 
 84 
Tuberculosis (TB) remains an important public health concern in European 85 
countries (1–3). Immigrants from high TB-incidence countries and HIV-infected 86 
populations are common risk groups in Switzerland, as in other European countries 87 
(4–8). We and others have previously shown that transmission of Mycobacterium 88 
tuberculosis occurs, but is not more common among immigrants than in the native 89 
population (9–12).  90 
Mycobacterial interspersed repetitive-unit–variable-number tandem-repeat 91 
(MIRU-VNTR), combined with spoligotyping (13, 14), remains the most commonly 92 
used genotyping method in molecular epidemiology of TB (15). However, MIRU-93 
VNTR may not distinguish between genetically closely related strains despite the 94 
absence of close epidemiological links between patients (16–18). MIRU-VNTR may 95 
be suboptimal to study transmission among immigrants from high TB incidence 96 
countries, where genetically closely related strains circulate over extended periods of 97 
time (19). Hence, recent transmission among immigrants is potentially overestimated, 98 
but the extent of this phenomenon is largely unknown. In contrast to standard 99 
genotyping methods, whole genome sequencing (WGS) provides an increased 100 
resolution and has been used to study M. tuberculosis transmission (20–24). In this 101 
study, we re-analyzed transmission clusters previously defined by MIRU-VNTR, 102 
using WGS to assess transmission of M. tuberculosis among Swiss- and foreign-born 103 
TB patients (9). 104 
 105 
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MATERIALS AND METHODS 107 
 108 
Study setting and study population 109 
In 2012, we conducted a nationwide study of the molecular epidemiology of TB 110 
in Switzerland as a collaborative project between the Swiss HIV Cohort Study 111 
(SHCS), the National Center for Mycobacteria, diagnostic microbiology laboratories, 112 
departments of respiratory medicine and public health, and the Federal Office of 113 
Public Health (www.tb-network.ch) (9, 25–28). The study setting was previously 114 
described in detail (9). Briefly, all patients in the SHCS diagnosed with TB between 115 
2000 and 2008 were enrolled (n=93). In addition, we included a random sample of 116 
288 TB cases from the 4,221 culture-confirmed TB patients reported to the National 117 
TB Surveillance Registry, and all drug-resistant TB cases reported in Switzerland 118 
(n=167) during the same period (categories not mutually exclusive). 24-loci MIRU-119 
VNTR and spoligotyping were used for the molecular detection of transmission 120 
clusters (9). In this follow-up study, we performed WGS on the 90 M. tuberculosis 121 
isolates belonging to one of the 35 MIRU-VNTR/spoligotyping clusters. 122 
 123 
Clinical data collection and definitions 124 
The clinical data collection was previously described in detail (9). The clustering 125 
proportion was determined by the “n” method expressed as the number of patients in 126 
clusters divided by the total number of individuals (29). MIRU-VNTR clusters were 127 
defined as a group of isolates with identical MIRU-VNTR and spoligotyping patterns 128 
(9). In addition, we used IS6110-Restriction Fragment Length Polymorphism (RFLP) 129 
patterns, when available from the National Center for Mycobacteria (30). RFLP has a 130 
higher resolution than MIRU-VNTR, particularly in strains of the “Beijing” genotype. 131 
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Isolates with identical MIRU-VNTR and spoligotype patterns, but different IS6110 132 
patterns, were considered as non-clustered. “Mixed” molecular clusters were defined 133 
as clusters with Swiss-born and foreign-born individuals, or foreign-born individuals 134 
from different continents. 135 
 136 
Whole genome sequencing and phylogenetic analyses 137 
We generated whole genome sequences for all 90 patient isolates identified as 138 
part of MIRU-VNTR clusters (9). We used Illumina Nextera XT or TruSeq library 139 
preparation kits and Illumina HiSeq, MiSeq or NextSeq devices (Illumina, San Diego, 140 
CA) for WGS according to manufacturer’s instructions. Isolates were re-sequenced 141 
when the mean read depth was below 20x. FastQ files from multiple sequencing runs 142 
of the same isolate were merged. We used KvarQ for initial quality check, 143 
determination of M. tuberculosis phylogenetic lineages and in silico spoligotyping 144 
pattern, as previously described (31). We then mapped short sequencing reads to a 145 
hypothetical M. tuberculosis ancestral genome (identical with H37Rv in structure, but 146 
with maximum likelihood-inferred ancestral bases (32), with BWA 0.6.2 (33)). 147 
Samtools 0.1.19 was used to call variants (SNPs). We only retained positions with a 148 
read depth of ≥10% and ≤200% of the average read depth for the whole genome, 149 
and a phred-scaled quality score of ≥30. We excluded positions in known repetitive 150 
regions (23), as well as SNPs in genes in which we have previously identified 50 bp 151 
sequences with homologous sequences elsewhere on the genome (Supplementary 152 
Table 1). We also excluded positions associated with drug resistance (31). For the 153 
analyses of read/allele counts at particular genomic loci, we extracted the number of 154 
high quality bases from Variant Call Format (VCF)-files with SNPeff/SNPsift (34). 155 
 156 
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Transmission networks based on SNP distances 157 
We generated an alignment of all variable positions across the 90 isolates. We 158 
then calculated the raw genetic distances (number of SNPs) for each isolate pair in 159 
each MIRU-VNTR cluster with the “Compute Pairwise Distances” function (using the 160 
“Pairwise deletion” option) in MEGA 5.2.2 (35). We defined a MIRU-VNTR cluster as 161 
a “true“ transmission cluster if all isolate pairs in the cluster were separated by ≤12 162 
SNPs. In a sensitivity analysis, we opted for a stricter definition, whereby a MIRU-163 
VNTR transmission cluster was considered as confirmed if at least one of its isolate 164 
pairs was separated by ≤5 SNPs. These thresholds of 12 and 5 SNPs were 165 
previously established by Walker et al. (17). We imported an alignment of the 166 
variable genomic positions into popart (http://popart.otago.ac.nz) to generate median 167 
joining networks. Networks were generated for all 35 transmission clusters identified 168 
by standard genotyping (MIRU-VNTR and spoligotyping) (9).  169 
 170 
Statistical analysis 171 
We re-analyzed risk factors for transmission using the WGS-based (“true”) 172 
cluster definition. We used weighted logistic regression models to obtain age- and 173 
sex-adjusted odds ratios (aOR) for the probability of belonging to a true molecular 174 
cluster. We used the Kruskal-Wallis rank sum test to assess differences between 175 
mean genetic distances of Swiss-born, foreign-born and mixed clusters. As our study 176 
sample included, by design, more HIV-infected and patients with drug-resistant TB 177 
(9), we calculated weights to take sampling proportions into account. As a sensitivity 178 
analysis, we restricted the analysis of clustering proportion to the patients in the 179 
random sample from the TB registry (n=288) (9). All statistical analyses were 180 
performed in Stata version 14 (Stata Corporation, College Station, TX) and R 3.1.2 181 
(36). 182 
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In addition, we plotted the mean genetic distances (in SNPs) versus the mean 183 
geographical distances (in km) of all patient pairs in a molecular cluster (distance 184 
between the birth countries’ capital cities). Plots were generated with the ggplot2 185 
library in R (37). 186 
 187 
Ethics approval 188 
The study was approved by the Ethics Committee of the Canton of Bern, 189 
Switzerland (9). Informed consent was obtained from all patients enrolled in the 190 
SHCS. For patients outside the SHCS, informed consent was obtained by the 191 
treating physicians. In some cases, informed consent could not be obtained from 192 
the patient, because he or she could not be located or was known to have died. 193 
For these cases, we obtained permission from the Federal Expert Commission on 194 
Confidentiality in Medical Research to use the data provided by the treating 195 
physician. 196 
 197 
  198 
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RESULTS 199 
 200 
Study population 201 
The study population consisted of 520 TB patients from the nationwide study in 202 
Switzerland (9, 25, 27, 28, 38). The patient characteristics are described in Table 1. A 203 
total of 119 (22.9%) patients were born in Switzerland and 401 (77.1%) abroad. 204 
Median age was 36.5 years (Interquartile Range 28–51). Overall, 113 (21.7%) 205 
patients were HIV positive. Pulmonary TB accounted for 387 (74.4%) of all cases and 206 
extrapulmonary TB for 133 (25.6%) (Table 1). 207 
 208 
Transmission clusters 209 
Whole genome sequencing 210 
Isolates were sequenced with a median sequencing depth of 130x (range 22-211 
274x). For quality assurance, we compared laboratory-assay-based phylogenetic 212 
lineage classification and spoligotyping pattern with the results generated from the 213 
WGS data using KvarQ (9). We found 100% agreement between the two methods for 214 
lineage identification and up to two discordant spacers in the spoligotyping patterns. 215 
Identification of molecular clusters based on WGS 216 
In the 35 previously defined MIRU-VNTR clusters, we found pairwise genetic 217 
distances of 0 to 224 SNPs (median: 21.5 SNPs) (Figure 1 and Supplementary 218 
Figure 1). In the largest cluster (eight isolates), genetic distances were ≥54 SNPs. 219 
Seventeen of 35 (48.6%) MIRU-VNTR clusters consisted of pairs separated by ≤12 220 
SNPs, i.e. were confirmed as true transmission clusters, corresponding to 43 of 90 221 
patients (47.8%) (Table 2). The remaining 18 clusters harbored isolate pairs 222 
separated by >12 SNPs (47 patients). 223 
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The overall clustering proportion decreased from 17.3% (95% confidence 224 
interval [95% CI]: 14.2-20.8%) based on standard genotyping (spoligotyping and 225 
MIRU-VNTR), to 8.3% (95% CI: 6.0-11.0%) based on WGS. When restricting the 226 
analysis to the 288 randomly selected patients, we found 27 clustered patients in 11 227 
genome-based clusters, resulting in a clustering proportion of 9.4% (95% CI: 6.3-228 
13.3%). When using a more stringent WGS definition for transmission clusters (at 229 
least one isolate pair in a cluster ≤5 SNPs distance), 13 of 35 (37.1%, CI: 21.5-230 
55.1%) MIRU-VNTR clusters were confirmed. These 13 transmission clusters 231 
included 35/520 patients, corresponding to a clustering proportion of 6.7% (95% CI: 232 
4.7-9.2%).  233 
Infection with multiple M. tuberculosis strains 234 
In five isolates that were part of transmission clusters defined by MIRU-VNTR, 235 
we detected multiple alleles at several MIRU-VNTR loci, potentially indicating 236 
infection with multiple M. tuberculosis strains. We therefore conducted an allele 237 
frequency analysis based on sequencing reads for each SNP call. Despite the 238 
presence of multi-allelic variant calls in all isolates (potential microevolutionary 239 
events), none of the five isolates with multiple MIRU-VNTR bands showed evidence 240 
of lineage- or sublineage-specific markers with multiple alleles in the sequencing 241 
reads. 242 
 243 
Molecular clustering in Swiss-born, foreign-born and HIV-positive patients 244 
Four MIRU-VNTR clusters involved Swiss-born patients only, 16 clusters 245 
foreign-born only and 15 clusters were of mixed birth group origin. Three of four 246 
clusters (75.0%) involving only Swiss-born patients were confirmed by WGS as true 247 
clusters (8/10 [80.0%] clustered Swiss-born patients). On the other hand, only 4/16 248 
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(25.0%) immigrant clusters (born on the same continent) were true clusters (8/37 249 
[21.6%] patients). Of the 15 mixed clusters, 10 (66.7%) were true clusters (27/43 250 
[62.8%] clustered patients) (Table 2). We assessed whether foreign-born patients 251 
were overrepresented in MIRU-VNTR clusters not confirmed by WGS. Among all 90 252 
patients from the MIRU-VNTR clusters, foreign-born patients were more likely in 253 
clusters not confirmed by WGS compared to true clusters (aOR 4.5, CI: 1.5-13.6 254 
p=0.008) (Table 2). 255 
We then calculated the true (genome-based) clustering proportion for both 256 
Swiss- and foreign-born patients. The clustering proportion among Swiss-born cases 257 
decreased only slightly, from 19.3% (23/119, 95% CI: 12.7-27.6%) using MIRU-258 
VNTR to 14.3% (17/119, 95% CI: 8.5-21.9) using WGS data. In contrast, the 259 
clustering proportion among immigrants was more than halved, from 16.7% (67/401, 260 
95% CI: 13.2-20.7) to 6.5% (26/401, 95% CI: 4.3-9.4). Figure 2 summarizes the 261 
possible factors leading to an overestimation of M. tuberculosis transmission based 262 
on standard genotyping, among foreign-born and native TB patients in low TB 263 
incidence settings. 264 
The median genetic distance differed significantly between the three groups: 9 265 
SNPs (range 8-15) in clusters with Swiss-born individuals only, 2 SNPs (range 0-162) 266 
in mixed clusters, and 24 SNPs (2-224) in clusters with foreign-born individuals only 267 
(p=0.030, Figure 3). 268 
 269 
Geographical and genetic distances within molecular clusters 270 
Plotting the mean genetic distance (in SNPs) versus the mean geographical 271 
distance between patient origins (capital cities) for each molecular cluster further 272 
supported the different patterns of clustering by birth origin of the patients 273 
(Supplementary Figure 2). Among foreign-born patients, a majority of MIRU-VNTR 274 
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clusters (11/16, 68.8%) consisted of patients born within 3,500 km of geographic 275 
distance, but harboring genetic distances of >12 SNPs. This indicates that genetically 276 
closely related strains, circulating in a geographically restricted area in the region of 277 
origin, were imported to Switzerland. Among the mixed MIRU-VNTR clusters, for 278 
which transmission is expected to have happened in Switzerland, a majority of 279 
clusters (9/15, 60%) had mean geographic distances above 3,500 km, but genetic 280 
distances of ≤12 SNPs, indicating recent transmission in Switzerland (Supplementary 281 
Figure 2). 282 
 283 
Risk factors for transmission 284 
Female (aOR 0.39, CI: 0.18-0.85) and HIV-positive patients (aOR 0.39, CI: 0.16-285 
0.93) were significantly less likely to be involved in true transmission clusters (Table 286 
1). In contrast, patients with cavitary disease were more likely to be associated with 287 
transmission (aOR 2.31, CI: 1.05-5.10). There was a weak evidence for an 288 
association between being born in Switzerland and being involved in a true 289 
transmission cluster (aOR 2.21, 95% CI: 0.88-5.52 for Swiss-born compared to 290 
foreign-born patients). Overall, the risk factors for transmission remained similar to 291 
those previously reported when using standard genotyping methods (9). 292 
  293 
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DISCUSSION 294 
 295 
In this nationwide study on 520 TB patients, 18 of 35 transmission clusters 296 
identified by standard molecular genotyping (spoligotyping and MIRU-VNTR) were 297 
refuted by WGS. This suggests that transmission of M. tuberculosis is generally 298 
overestimated in low TB incidence countries such as Switzerland. Furthermore, we 299 
found a striking difference between transmission clusters involving Swiss-born cases 300 
and clusters involving foreign-born patients. WGS confirmed three quarters of the 301 
clusters involving Swiss-born individuals only, but only one quarter of clusters 302 
involving foreign-born patients only, hence indicating that transmission was especially 303 
overestimated among the immigrant population. 304 
M. tuberculosis strains from immigrants, which were defined as clustered by 305 
MIRU-VNTR, but not by WGS, are likely genetically closely related genotypes, 306 
imported independently from a high-incidence region, where they are highly prevalent 307 
(19). Such strains accumulate genetic mutations over time (often leading to pairwise 308 
SNP distances of >12 SNPs), but the MIRU-VNTR pattern may not change. In such a 309 
situation, identical MIRU-VNTR will be wrongly interpreted as recent transmission in 310 
the country of immigration (9). Similar observations were made in the UK, where 311 
immigrant TB cases were identified in transmission clusters based on standard 312 
MIRU-VNTR genotyping, although no epidemiological link could be found during 313 
contact investigations (16).  314 
The clustering proportion (indicating recent transmission) among Swiss-born 315 
individuals was similar using standard genotyping and WGS, but more than two-fold 316 
lower among foreign-born individuals when using WGS. In reality, the clustering 317 
proportion among foreign-born individuals might even be lower, as we cannot 318 
exclude that WGS-confirmed clusters (≤12 SNPs) involving immigrants might partly 319 
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represent transmission that happened in the country of origin and not in Switzerland. 320 
Only social contact tracing could provide further insights into transmission dynamics, 321 
but such investigations are notoriously difficult to perform, particularly among 322 
immigrants (23, 39). The low proportion of true transmission clusters among 323 
immigrants in our study was further supported by the weighted analysis of predictors 324 
for transmission, which showed that foreign-born TB cases tended to be less likely 325 
involved in true clusters compared to Swiss-born cases. Of note, the clustering 326 
proportion among immigrants is remarkably similar to previous observations among 327 
immigrant MDR cases diagnosed in Switzerland, which showed a clustering 328 
proportion of 8% (compared to 7% in our study) based on standard genotyping and 329 
contact tracing (30). 330 
The majority of mixed molecular clusters as defined by MIRU-VNTR (i.e. 331 
involving Swiss- and foreign-born individuals) showed small SNP distances (≤12 332 
SNPs), confirming the intuitive explanation that transmission between Swiss-born 333 
and foreign-born likely occurred in Switzerland. This was further supported by the 334 
analysis of geographical distances between patient birth countries, which indicated 335 
that most isolate pairs in the mixed clusters were from patients born far away from 336 
each other, despite small genetic distances. The five mixed clusters harboring larger 337 
SNP distances may reflect TB cases due to infections by circulating global or 338 
European M. tuberculosis genotypes, such as the recently described large cluster in 339 
Eastern Europe (40). 340 
We found no evidence of infection with multiple strains among clustered TB 341 
cases using the WGS data, despite the presence of double alleles in the MIRU-VNTR 342 
patterns of five clustered isolates. Infections with multiple strains could potentially 343 
also influence the identification of molecular clusters, as individual strains in an 344 
infection with multiple strains cannot be resolved by MIRU-VNTR typing. The 345 
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prevalence and relevance of such multiple infections need to be further studied (41–346 
43).  347 
A potential limitation of our study is the definition of transmission clusters by 348 
WGS. The threshold of 12 SNPs, which we used to exclude transmission, has been 349 
established by Walker et al. (17) and is in the range of what other studies have used 350 
(21, 44, 45). However, an adequate cluster definition may be adapted according to 351 
the setting (low versus high TB incidence), the study population and the technical 352 
specifications of the WGS analysis pipeline (i.e. whether particular genomic regions 353 
such as the PE/PGRS genes are excluded from the analysis, which was the case 354 
here). For comparison, we repeated the analyses with a stricter definition of 355 
transmission clusters also proposed by Walker et al. (MIRU-VNTR clusters in which 356 
at least one pairwise distance was ≤5 SNPs (17)), which further reduced the number 357 
of true clusters to 13, but did not change the overall clustering proportion significantly. 358 
A further limitation may be our sample size: we included 12.3% of all TB cases 359 
diagnosed between 2000 and 2008 in Switzerland, which potentially underestimates 360 
the overall clustering proportion (29). Indeed, SNP distances could in fact become 361 
shorter upon inclusion of additional patient isolates with intermediate genotypes, 362 
hence increasing the proportion of true clusters.  363 
In conclusion, only one quarter of foreign-born transmission clusters previously 364 
identified by MIRU-VNTR were confirmed as true transmission clusters by WGS. We 365 
therefore recommend the use of WGS for a more accurate identification of recent 366 
transmission of M. tuberculosis among immigrants in low TB incidence countries, but 367 
also in high TB incidence countries, where genetically closely related strains 368 
circulate. Although analyzing WGS remains resource-intensive, the strategy adopted 369 
in the UK documents that implementing WGS in the routine public laboratory 370 
surveillance system is feasible (21, 46), and allows the prompt identification of 371 
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transmission clusters as well as information about the drug resistance genotype (46, 372 
47). Our results also indicate that the native population in Switzerland may also play 373 
a role in spreading TB, particularly individuals belonging to high risk populations (22, 374 
23). Additional prospective studies using WGS are needed, possibly complemented 375 
with social network analyses (20), to evaluate the usefulness of real-time analyses of 376 
TB transmission dynamics in low TB incidence countries. 377 
 378 
  379 
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TABLES 640 
Table 1. Patient characteristics of tuberculosis (TB) cases diagnosed in Switzerland 641 
between 2000 and 2008, overall and comparing clustered and unclustered TB 642 
cases (unweighted), as well as risk factors for transmission (weighted analysis) as 643 
defined by genome-based molecular clustering. 644 
Characteristic Unweighted (n=520) Weighted (n=4,221) 
 All cases 
n=520 
Clustered 
n=43 
Unclustered 
n=477 
Adjusted Odds 
Ratio (95% CI) * 
P-value 
 n (%) n (%) n (%)   
Age at TB diagnosis, years        0.46 
16-29 154 (29.6) 14 (32.6) 140 (29.4) 1  
30-49 226 (43.5) 16 (37.2) 210 (44.0) 0.56 (0.22-1.41)  
≥50 140 (26.9) 13 (30.2) 127 (26.6) 0.71 (0.29-1.73)  
         
Sex        0.018 
Male 254 (48.8) 26 (60.5) 228 (47.8) 1   
Female 266 (51.2) 17 (39.5) 249 (52.2) 0.4 (0.18-0.85)  
         
Country of birth        0.026 
Switzerland 119 (22.9) 17 (39.5) 102 (21.4) 1  
Europe, without 
Switzerland 
106 (20.4) 2 (4.7) 104 (21.8) 0.16 (0.03-0.83)  
Asia 120 (23.1) 3 (7.0) 117 (24.5) 0.24 (0.05-1.08)  
Sub-Saharan Africa 132 (25.4) 16 (37.2) 116 (24.3) 1.11 (0.36-3.45)  
Central and South 
America 
20 (3.8) 3 (7.0) 17 (3.6) 1.99 (0.40-9.85)  
Other regions/Unknown 23 (4.4) 2 (4.7) 21 (4.4) 0.80 (0.13-5.02)  
         
Born in Switzerland         0.091 
No 401 (77.1) 26 (60.5) 375 (78.6) 1  
Yes 119 (22.9) 17 (39.5) 102 (21.4) 2.21 (0.88-5.52)  
         
Residence status        0.41 
Swiss nationals 130 (25.0) 14 (32.6) 116 (24.3) 1  
Foreigner/Residents 199 (38.3) 11 (25.6) 188 (39.4) 0.45 (0.17-1.23)  
Asylum seeker/Refugee 101 (19.4) 8 (18.6) 93 (19.5) 0.42 (0.11-1.56)  
Unknown 90 (17.3) 10 (23.3) 80 (16.8) 0.80 (0.22-2.81)  
         
HIV status        0.033 
Negative 407 (78.3) 34 (79.1) 373 (78.2) 1  
Positive 113 (21.7) 9 (20.9) 104 (21.8) 0.39 (0.16-0.93)  
         
Site of disease        0.054 
Extra-pulmonary TB 133 (25.6) 5 (11.6) 128 (26.8) 1  
Pulmonary TB 387 (74.4) 38 (88.4) 349 (73.2) 3.14 (0.98-10.07)  
         
Cavitary disease        0.039 
No 407 (78.3) 28 (65.1) 379 (79.5) 1  
Yes 113 (21.7) 15 (34.9) 98 (20.5) 2.31 (1.05-5.10)  
         
Positive smear 
microscopy 
       0.049 
No 352 (67.7) 21 (48.8) 331 (69.4) 1  
Yes 168 (32.3) 22 (51.2) 146 (30.6) 2.18 (1.00-4.73)  
         
TB in family or social 
surroundings in last 2 
years 
       0.068 
No 482 (92.7) 38 (88.4) 444 (93.1) 1  
Yes 38 (7.3) 5 (11.6) 33 (6.9) 2.95 (0.92-9.41)  
* Adjusted for age and sex, and weighted for sampling proportions 645 
95% CI, 95% confidence iInterval; TB, tuberculosis  646 
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Table 2. Number of MIRU-VNTR clusters and number of patients in MIRU-647 
VNTR clusters confirmed by whole genome sequencing. MIRU-VNTR clusters 648 
not confirmed by WGS (“false positive” clusters) and clusters confirmed by WGS 649 
(“true” clusters) are presented, according to the countries of birth of cases involved: 650 
clusters involving Swiss-born TB cases only, foreign-born cases only, or mixed 651 
clusters (e.g., involving both Swiss-born and foreign-born TB cases, or foreign-born 652 
cases from different continents).  653 
 
MIRU-VNTR 
clusters confirmed 
by WGS 
n (%)
MIRU-VNTR 
clusters not 
confirmed by WGS  
n (%) 
Total 
number of 
clusters
n
Molecular clusters *  
Swiss-born only 3 (75.0) 1 (25.0) 4
Mixed 10 (66.7) 5 (33.3) 15
Foreign-born only 4 (25.0) 12 (75.0) 16
Total 17 (48.6) 18 (51.4) 35
   
Patients in molecular clusters **  
Swiss-born only 8 (80.0) 2 (20.0) 10
Mixed 27 (62.8) 16 (37.2) 43
Foreign-born only 8 (21.6) 29 (78.4) 37
Total 43 (47.8) 47 (52.2) 90
MIRU-VNTR, mycobacterial interspersed repetitive-unit–variable-number tandem-repeat; 654 
WGS, whole genome sequencing 655 
 656 
* Fisher’s exact test: p-value=0.031 657 
** Fisher’s exact test: p-value <0.0001 658 
 659 
  660 
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FIGURES 661 
 662 
Figure 1. M. tuberculosis transmission network using SNP data from whole 663 
genome sequencing. Representative examples of different types of transmission 664 
clusters that were previously identified by MIRU-VNTR: cluster A (all patients from 665 
Switzerland) was confirmed as a true transmission cluster by WGS, with distances 666 
of ≤12 SNPs between all isolates. Cluster B is a mixed cluster (one patient from 667 
Switzerland and two patients from West Africa), which was confirmed to be a true 668 
transmission cluster with one and two SNPs between patient isolates. Clusters C 669 
and D were identified by MIRU-VNTR as transmission clusters, but WGS did not 670 
confirm these clusters as true clusters (genetic distances of >12 SNPs). Filled 671 
circles represent patient isolates, white circles „median vectors“, i.e. hypothetical 672 
isolates inferred from the sequencing data. Blue circles indicate HIV-positive 673 
patients. Numbers next to lines indicate SNP distances. Countries of birth and years 674 
of tuberculosis diagnosis are indicated next to circles. Clusters with solid lines are 675 
“true” clusters, i.e. clusters confirmed by WGS (≤12 SNPs), whereas clusters with 676 
dashed lines are clusters not confirmed by WGS (>12 SNPs). All other transmission 677 
clusters are shown in Supplementary Figure 1. 678 
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Figure 2. Possible situations leading to an overestimation of M. tuberculosis 681 
transmission in a low tuberculosis incidence country. 682 
 683 
MIRU-VNTR, mycobacterial interspersed repetitive-unit–variable-number tandem-684 
repeat; TB, tuberculosis; WGS, whole genome sequencing 685 
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Figure 3. Median genetic distance in MIRU-VNTR-defined transmission 687 
clusters. Each data point shows the mean genetic distance (as number of single 688 
nucleotide polymorphisms [SNPs]) in one of the 35 MIRU-VNTR-defined 689 
transmission clusters. Solid black lines indicate median values of mean pairwise 690 
distances within molecular clusters. The distribution of clusters with patients born in 691 
Switzerland, mixed clusters and immigrant patients born on the same continent 692 
(except Switzerland) was significantly different (Kruskal-Wallis non-parametric test, 693 
p=0.030). The dashed line represents the cut-off for the definition of genome-based 694 
molecular clusters (≥12 SNPs). 695 
 696 
 697 
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